Gaucher's disease - Market Insights, Epidemiology & Market Forecasts - 2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Gaucher's disease - Market Insights, Epidemiology and Market Forecast - 2023 - Japan" drug pipelines to their offering.

The report provides an overview of the disease and global market size of the Gaucher's disease for the 7MM. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Gaucher's disease from 2010-2023.

Gaucher disease is an inherited genetic disease that causes fatty lipid deposits to build up in certain organs and bones. It is an autosomal recessive disorder. Gaucher Disease is the second most common lysosomal storage disorder. These fatty deposits are of an enzyme glucocerebrosidase in the lymphocyte which leads to bloating of cells.

Scope of the Report:

  • Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details.
  • The report also covers the detailed global historical and forecasted epidemiological data covering 7MM from 2010-2023.
  • It also provides Market size of Gaucher's disease for 7MM from 2010 and forecasted Market size to 2023.

Key Topics Covered:

  1. Report Introduction
  2. Gaucher's disease Market Overview at a Glance
  3. Total Market Size of Gaucher's disease for 7 MM in 2013-2023
  4. Total Market Share Distribution of Gaucher's disease for 7 MM in 2015
  5. Total Market Share Distribution of Gaucher's disease for 7 MM in 2023
  6. Overview
  7. Symptoms
  8. Pathophysiology
  9. Staging
  10. Diagnosis
  11. Treatment
  12. Epidemiology and Patient Population
  13. Diagnosed Cases of Gaucher's disease in United States
  14. Diagnosed Cases of Gaucher's disease in Germany
  15. Diagnosed Cases of Gaucher's disease in France
  16. Diagnosed Cases of Gaucher's disease in United Kingdom
  17. Diagnosed Cases of Gaucher's disease in Spain
  18. Diagnosed Cases of Gaucher's disease in Italy
  19. Diagnosed Cases of Gaucher's disease in Japan
  20. Top Marketed Drugs for Gaucher's disease
  21. Market Drivers
  22. Market Restraints
  23. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/7xwprb/gauchers_disease

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs